EVALUATION OF COVID-19 VACCINES IN PRIMARY PREVENTION AGAINST INFECTIONS AND REDUCTION IN SEVERITY OF ILLNESS FOLLOWING THE OUTBREAK OF SARS-COV-2 OMICRON VARIANT IN SHANGHAI

被引：0

作者：

Yang, D. ^{[1
]}

Weng, H. ^{[2
]}

Song, Y. ^{[1
]}

Li, J. ^{[3
]}

Lu, X. ^{[3
]}

Yang, W. ^{[2
]}

Chen, Z. ^{[4
]}

Xuan, J. ^{[3
]}

Bai, C. ^{[1
]}

Wang, Y. ^{[5
]}

机构：

[1] Fudan Univ, Dept Pulm & Crit Care Med, Zhongshan Hosp, Shanghai, Peoples R China

[2] Suvalue Healthcare Sci Co Ltd, Shanghai, Peoples R China

[3] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China

[4] Guangzhou Med Univ, Dept Clin Res Management Off, Affiliated Hosp 3, Guangzhou, Peoples R China

[5] Army Med Univ, Inst Surg Res, Daping Hosp,Wound Trauma Med Ctr, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 06期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EPH100

引用

页码：S182 / S182

页数：1

共 50 条

[41] Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting
Rane, Madhura S.
Robertson, McKaylee M.
Kulkarni, Sarah G.
Frogel, Daniel
Gainus, Chris
Nash, Denis
VACCINE, 2023, 41 (04) : 989 - 998
[42] Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection
Zhu, Zhuxian
Cai, Jixu
Tang, Qiang
Mo, Yin-yuan
Deng, Tiantian
Zhang, Xiaoyu
Xu, Ke
Wu, Beishou
Tang, Haicheng
Zhang, Ziqiang
BMC PULMONARY MEDICINE, 2023, 23 (01)
[43] Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection
Zhuxian Zhu
Jixu Cai
Qiang Tang
Yin-yuan Mo
Tiantian Deng
Xiaoyu Zhang
Ke Xu
Beishou Wu
Haicheng Tang
Ziqiang Zhang
BMC Pulmonary Medicine, 23
[44] Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou, Zhou
Zhu, Yimiao
Chu, Ming
FRONTIERS IN IMMUNOLOGY, 2022, 13
[45] COVID-19 vaccines and decreased transmission of SARS-CoV-2
Vitiello, A.
Ferrara, F.
Troiano, V
La Porta, R.
INFLAMMOPHARMACOLOGY, 2021, 29 (05) : 1357 - 1360
[46] COVID-19 vaccines and decreased transmission of SARS-CoV-2
A. Vitiello
F. Ferrara
V. Troiano
R. La Porta
Inflammopharmacology, 2021, 29 : 1357 - 1360
[47] Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong
Guo, Zihao
Zhao, Shi
Lee, Shui Shan
Mok, Chris Ka Pun
Wong, Ngai Sze
Wang, Jingxuan
Jia, Katherine Min
Wang, Maggie Haitian
Yam, Carrie Ho Kwan
Chow, Tsz Yu
Chong, Ka Chun
Yeoh, Eng Kiong
JOURNAL OF TRAVEL MEDICINE, 2022, 29 (06)
[48] Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality
Marziano, Valentina
Guzzetta, Giorgio
Menegale, Francesco
Sacco, Chiara
Petrone, Daniele
Mateo Urdiales, Alberto
Del Manso, Martina
Bella, Antonino
Fabiani, Massimo
Vescio, Maria Fenicia
Riccardo, Flavia
Poletti, Piero
Manica, Mattia
Zardini, Agnese
d'Andrea, Valeria
Trentini, Filippo
Stefanelli, Paola
Rezza, Giovanni
Palamara, Anna Teresa
Brusaferro, Silvio
Ajelli, Marco
Pezzotti, Patrizio
Merler, Stefano
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (08)
[49] SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
Ahmed, Syed Faraz
Quadeer, Ahmed Abdul
McKay, Matthew R.
VIRUSES-BASEL, 2022, 14 (01):
[50] Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines
Soffritti, Irene
D'Accolti, Maria
Bini, Francesca
Mazziga, Eleonora
Proietto, Davide
Dallan, Beatrice
De Laurentis, Martina
Ghisellini, Sara
Nicoli, Francesco
Caselli, Elisabetta
VIRUSES-BASEL, 2023, 15 (12):

← 1 2 3 4 5 →